Highlights from this edition:

  • Gedi Cube was acquired by Renovaro Biosciences Inc. (NasdaqCM:RENB)
  • Repligen Corporation (NasdaqGS:RGEN) announced its acquisition of Metenova AB
  • Harbinger Health closed a $140MM Series A Financing, led by Flagship Pioneering